Sinopharm Modern (600420.SH): Tacrolimus Ointment Obtained Drug Registration Certificate

Zhitong Finance APP News, Sinopharm Modern (600420.SH) announced that recently, the company received the "Drug Registration Certificate" for Tacrolimus Ointment approved and issued by the National Medical Products Administration. Tacrolimus Ointment is a non-steroidal immunomodulatory drug, indicated for patients with moderate to severe atopic dermatitis who are not suitable for traditional therapies due to potential risks, or who have an inadequate response to traditional therapies, or who cannot tolerate traditional therapies. It can be used as short-term or intermittent long-term treatment. The 0.03% concentration can be used in children aged 2 years and older.